Literature DB >> 24724482

Serum paraoxonase-1 activity of dairy Holstein-Fresian cows in different lactation stages--preliminary study.

M Kulka, J Bełtowski, W Kluciński, M Orłowska, J Kołodziejska, M Kleczkowski.   

Abstract

The objective of this study was to investigate paraoxonase-1 (PON-1) activity in different lactation stages. The study was conducted on Holstein--Friesian dairy cows in 2nd and 3rd lactation. A significant decrease in paraoxonase activity was found in the postpartum period and during peak of lactation. Serum triglyceride and cholesterol concentration were also markedly reduced during postpartum period. The concentrations of uric acid in serum was 23% higher during lactation peak in comparison with dry and postpartum period. The results indicate that lower serum paraoxonase activity and higher concentration of uric acid are associated with oxidative character of transition period and lipid functional antioxidative protection during intensive milk production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24724482     DOI: 10.2478/pjvs-2014-0019

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  3 in total

1.  Metabolomics Analysis Across Multiple Biofluids Reveals the Metabolic Responses of Lactating Holstein Dairy Cows to Fermented Soybean Meal Replacement.

Authors:  Zuo Wang; Yuannian Yu; Weijun Shen; Zhiliang Tan; Shaoxun Tang; Hui Yao; Jianhua He; Fachun Wan
Journal:  Front Vet Sci       Date:  2022-05-13

2.  Predictive Value of Plasma Parameters in the Risk of Postpartum Ketosis in Dairy Cows.

Authors:  Yu Cao; Jiang Zhang; Wei Yang; Cheng Xia; Hong-You Zhang; Yan-Hui Wang; Chuang Xu
Journal:  J Vet Res       Date:  2017-04-04       Impact factor: 1.744

3.  Changes in Saliva Analytes in Dairy Cows during Peripartum: A Pilot Study.

Authors:  María D Contreras-Aguilar; Pedro J Vallejo-Mateo; Elsa Lamy; Damián Escribano; Jose J Cerón; Fernando Tecles; Camila P Rubio
Journal:  Animals (Basel)       Date:  2021-03-09       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.